nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—CYP3A4—bone cancer	0.281	1	CbGaD
Saquinavir—ABCC1—Epirubicin—bone cancer	0.0655	0.126	CbGbCtD
Saquinavir—ABCC2—Carboplatin—bone cancer	0.045	0.0868	CbGbCtD
Saquinavir—ABCG2—Carboplatin—bone cancer	0.0407	0.0785	CbGbCtD
Saquinavir—ABCC2—Cisplatin—bone cancer	0.0385	0.0742	CbGbCtD
Saquinavir—ABCC1—Doxorubicin—bone cancer	0.0348	0.0671	CbGbCtD
Saquinavir—ABCG2—Cisplatin—bone cancer	0.0348	0.067	CbGbCtD
Saquinavir—ABCC1—Methotrexate—bone cancer	0.0337	0.065	CbGbCtD
Saquinavir—SLCO1A2—Methotrexate—bone cancer	0.0301	0.0581	CbGbCtD
Saquinavir—SLCO1B1—Methotrexate—bone cancer	0.0284	0.0548	CbGbCtD
Saquinavir—ABCC2—Doxorubicin—bone cancer	0.0258	0.0497	CbGbCtD
Saquinavir—ABCC2—Methotrexate—bone cancer	0.025	0.0481	CbGbCtD
Saquinavir—ABCG2—Doxorubicin—bone cancer	0.0233	0.0449	CbGbCtD
Saquinavir—ABCG2—Methotrexate—bone cancer	0.0226	0.0435	CbGbCtD
Saquinavir—ALB—Methotrexate—bone cancer	0.0156	0.03	CbGbCtD
Saquinavir—CYP2C9—Cisplatin—bone cancer	0.0129	0.0249	CbGbCtD
Saquinavir—ABCB1—Cisplatin—bone cancer	0.0125	0.0242	CbGbCtD
Saquinavir—ABCB1—Doxorubicin—bone cancer	0.0084	0.0162	CbGbCtD
Saquinavir—ABCB1—Methotrexate—bone cancer	0.00814	0.0157	CbGbCtD
Saquinavir—CYP2D6—Doxorubicin—bone cancer	0.00792	0.0153	CbGbCtD
Saquinavir—CYP3A4—Doxorubicin—bone cancer	0.00503	0.00971	CbGbCtD
Saquinavir—Atazanavir—CYP3A4—bone cancer	0.00109	0.335	CrCbGaD
Saquinavir—Lopinavir—CYP3A4—bone cancer	0.000775	0.239	CrCbGaD
Saquinavir—Nelfinavir—CYP3A4—bone cancer	0.00072	0.222	CrCbGaD
Saquinavir—Indinavir—CYP3A4—bone cancer	0.000661	0.204	CrCbGaD
Saquinavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000225	0.00452	CbGpPWpGaD
Saquinavir—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000224	0.0045	CbGpPWpGaD
Saquinavir—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000221	0.00444	CbGpPWpGaD
Saquinavir—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000207	0.00416	CbGpPWpGaD
Saquinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000203	0.00408	CbGpPWpGaD
Saquinavir—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000202	0.00406	CbGpPWpGaD
Saquinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000192	0.00387	CbGpPWpGaD
Saquinavir—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000188	0.00379	CbGpPWpGaD
Saquinavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000181	0.00365	CbGpPWpGaD
Saquinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00018	0.00361	CbGpPWpGaD
Saquinavir—CYP11A1—Biological oxidations—CYP3A4—bone cancer	0.000167	0.00337	CbGpPWpGaD
Saquinavir—CYP11A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000165	0.00332	CbGpPWpGaD
Saquinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000162	0.00325	CbGpPWpGaD
Saquinavir—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000161	0.00325	CbGpPWpGaD
Saquinavir—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00016	0.00321	CbGpPWpGaD
Saquinavir—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000155	0.00312	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—DHFR—bone cancer	0.000152	0.00306	CbGpPWpGaD
Saquinavir—CYP11A1—Corticotropin-releasing hormone—BRAF—bone cancer	0.000152	0.00305	CbGpPWpGaD
Saquinavir—CYP11A1—Biological oxidations—GSTP1—bone cancer	0.000143	0.00288	CbGpPWpGaD
Saquinavir—CYP11A1—Metapathway biotransformation—GSTP1—bone cancer	0.000141	0.00284	CbGpPWpGaD
Saquinavir—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00014	0.00282	CbGpPWpGaD
Saquinavir—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000138	0.00278	CbGpPWpGaD
Saquinavir—ALB—Platelet degranulation—SPARC—bone cancer	0.000133	0.00268	CbGpPWpGaD
Saquinavir—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000131	0.00265	CbGpPWpGaD
Saquinavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000131	0.00264	CbGpPWpGaD
Saquinavir—Pharyngitis—Methotrexate—bone cancer	0.000127	0.000863	CcSEcCtD
Saquinavir—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000127	0.00256	CbGpPWpGaD
Saquinavir—Urinary tract disorder—Methotrexate—bone cancer	0.000126	0.000858	CcSEcCtD
Saquinavir—Photosensitivity reaction—Doxorubicin—bone cancer	0.000126	0.000858	CcSEcCtD
Saquinavir—Hepatobiliary disease—Epirubicin—bone cancer	0.000126	0.000857	CcSEcCtD
Saquinavir—Weight increased—Doxorubicin—bone cancer	0.000126	0.000856	CcSEcCtD
Saquinavir—Epistaxis—Epirubicin—bone cancer	0.000126	0.000855	CcSEcCtD
Saquinavir—Urethral disorder—Methotrexate—bone cancer	0.000126	0.000852	CcSEcCtD
Saquinavir—Weight decreased—Doxorubicin—bone cancer	0.000125	0.000851	CcSEcCtD
Saquinavir—Sinusitis—Epirubicin—bone cancer	0.000125	0.00085	CcSEcCtD
Saquinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000125	0.00252	CbGpPWpGaD
Saquinavir—Hyperglycaemia—Doxorubicin—bone cancer	0.000125	0.000848	CcSEcCtD
Saquinavir—Pneumonia—Doxorubicin—bone cancer	0.000124	0.000843	CcSEcCtD
Saquinavir—Infestation NOS—Doxorubicin—bone cancer	0.000124	0.000838	CcSEcCtD
Saquinavir—Infestation—Doxorubicin—bone cancer	0.000124	0.000838	CcSEcCtD
Saquinavir—Visual impairment—Methotrexate—bone cancer	0.000123	0.000838	CcSEcCtD
Saquinavir—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000123	0.00248	CbGpPWpGaD
Saquinavir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000122	0.000831	CcSEcCtD
Saquinavir—Hypersensitivity—Cisplatin—bone cancer	0.000122	0.000829	CcSEcCtD
Saquinavir—Renal failure—Doxorubicin—bone cancer	0.000121	0.000824	CcSEcCtD
Saquinavir—Erythema multiforme—Methotrexate—bone cancer	0.000121	0.000822	CcSEcCtD
Saquinavir—Neuropathy peripheral—Doxorubicin—bone cancer	0.000121	0.000822	CcSEcCtD
Saquinavir—Haemoglobin—Epirubicin—bone cancer	0.00012	0.000817	CcSEcCtD
Saquinavir—Jaundice—Doxorubicin—bone cancer	0.00012	0.000817	CcSEcCtD
Saquinavir—Stomatitis—Doxorubicin—bone cancer	0.00012	0.000817	CcSEcCtD
Saquinavir—Rhinitis—Epirubicin—bone cancer	0.00012	0.000815	CcSEcCtD
Saquinavir—Urinary tract infection—Doxorubicin—bone cancer	0.00012	0.000815	CcSEcCtD
Saquinavir—Conjunctivitis—Doxorubicin—bone cancer	0.00012	0.000815	CcSEcCtD
Saquinavir—Haemorrhage—Epirubicin—bone cancer	0.00012	0.000813	CcSEcCtD
Saquinavir—Hepatitis—Epirubicin—bone cancer	0.00012	0.000813	CcSEcCtD
Saquinavir—Eye disorder—Methotrexate—bone cancer	0.00012	0.000812	CcSEcCtD
Saquinavir—Tinnitus—Methotrexate—bone cancer	0.000119	0.00081	CcSEcCtD
Saquinavir—Hypoaesthesia—Epirubicin—bone cancer	0.000119	0.000809	CcSEcCtD
Saquinavir—Asthenia—Cisplatin—bone cancer	0.000119	0.000807	CcSEcCtD
Saquinavir—Pharyngitis—Epirubicin—bone cancer	0.000119	0.000807	CcSEcCtD
Saquinavir—Cardiac disorder—Methotrexate—bone cancer	0.000119	0.000807	CcSEcCtD
Saquinavir—Urinary tract disorder—Epirubicin—bone cancer	0.000118	0.000803	CcSEcCtD
Saquinavir—Connective tissue disorder—Epirubicin—bone cancer	0.000118	0.000799	CcSEcCtD
Saquinavir—Urethral disorder—Epirubicin—bone cancer	0.000117	0.000797	CcSEcCtD
Saquinavir—Hepatobiliary disease—Doxorubicin—bone cancer	0.000117	0.000793	CcSEcCtD
Saquinavir—Epistaxis—Doxorubicin—bone cancer	0.000117	0.000791	CcSEcCtD
Saquinavir—Angiopathy—Methotrexate—bone cancer	0.000116	0.000788	CcSEcCtD
Saquinavir—Sinusitis—Doxorubicin—bone cancer	0.000116	0.000786	CcSEcCtD
Saquinavir—Immune system disorder—Methotrexate—bone cancer	0.000116	0.000785	CcSEcCtD
Saquinavir—Visual impairment—Epirubicin—bone cancer	0.000115	0.000784	CcSEcCtD
Saquinavir—Mediastinal disorder—Methotrexate—bone cancer	0.000115	0.000783	CcSEcCtD
Saquinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000115	0.00231	CbGpPWpGaD
Saquinavir—Chills—Methotrexate—bone cancer	0.000115	0.00078	CcSEcCtD
Saquinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000114	0.00229	CbGpPWpGaD
Saquinavir—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000114	0.00228	CbGpPWpGaD
Saquinavir—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000113	0.00228	CbGpPWpGaD
Saquinavir—Diarrhoea—Cisplatin—bone cancer	0.000113	0.00077	CcSEcCtD
Saquinavir—Erythema multiforme—Epirubicin—bone cancer	0.000113	0.000769	CcSEcCtD
Saquinavir—Alopecia—Methotrexate—bone cancer	0.000113	0.000768	CcSEcCtD
Saquinavir—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000112	0.00226	CbGpPWpGaD
Saquinavir—Mental disorder—Methotrexate—bone cancer	0.000112	0.000761	CcSEcCtD
Saquinavir—Eye disorder—Epirubicin—bone cancer	0.000112	0.00076	CcSEcCtD
Saquinavir—Tinnitus—Epirubicin—bone cancer	0.000112	0.000758	CcSEcCtD
Saquinavir—Erythema—Methotrexate—bone cancer	0.000111	0.000757	CcSEcCtD
Saquinavir—Malnutrition—Methotrexate—bone cancer	0.000111	0.000757	CcSEcCtD
Saquinavir—Haemoglobin—Doxorubicin—bone cancer	0.000111	0.000756	CcSEcCtD
Saquinavir—Cardiac disorder—Epirubicin—bone cancer	0.000111	0.000755	CcSEcCtD
Saquinavir—Rhinitis—Doxorubicin—bone cancer	0.000111	0.000754	CcSEcCtD
Saquinavir—Hepatitis—Doxorubicin—bone cancer	0.000111	0.000753	CcSEcCtD
Saquinavir—Haemorrhage—Doxorubicin—bone cancer	0.000111	0.000753	CcSEcCtD
Saquinavir—Hypoaesthesia—Doxorubicin—bone cancer	0.00011	0.000749	CcSEcCtD
Saquinavir—Pharyngitis—Doxorubicin—bone cancer	0.00011	0.000747	CcSEcCtD
Saquinavir—Urinary tract disorder—Doxorubicin—bone cancer	0.00011	0.000743	CcSEcCtD
Saquinavir—Dysgeusia—Methotrexate—bone cancer	0.000109	0.000741	CcSEcCtD
Saquinavir—Connective tissue disorder—Doxorubicin—bone cancer	0.000109	0.00074	CcSEcCtD
Saquinavir—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000109	0.00219	CbGpPWpGaD
Saquinavir—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000109	0.00219	CbGpPWpGaD
Saquinavir—Angiopathy—Epirubicin—bone cancer	0.000109	0.000738	CcSEcCtD
Saquinavir—Urethral disorder—Doxorubicin—bone cancer	0.000109	0.000738	CcSEcCtD
Saquinavir—Immune system disorder—Epirubicin—bone cancer	0.000108	0.000735	CcSEcCtD
Saquinavir—Mediastinal disorder—Epirubicin—bone cancer	0.000108	0.000733	CcSEcCtD
Saquinavir—Back pain—Methotrexate—bone cancer	0.000108	0.000732	CcSEcCtD
Saquinavir—Chills—Epirubicin—bone cancer	0.000108	0.00073	CcSEcCtD
Saquinavir—Visual impairment—Doxorubicin—bone cancer	0.000107	0.000725	CcSEcCtD
Saquinavir—Alopecia—Epirubicin—bone cancer	0.000106	0.000719	CcSEcCtD
Saquinavir—Vomiting—Cisplatin—bone cancer	0.000105	0.000715	CcSEcCtD
Saquinavir—Mental disorder—Epirubicin—bone cancer	0.000105	0.000713	CcSEcCtD
Saquinavir—Erythema multiforme—Doxorubicin—bone cancer	0.000105	0.000712	CcSEcCtD
Saquinavir—Rash—Cisplatin—bone cancer	0.000105	0.000709	CcSEcCtD
Saquinavir—Dermatitis—Cisplatin—bone cancer	0.000104	0.000709	CcSEcCtD
Saquinavir—Malnutrition—Epirubicin—bone cancer	0.000104	0.000708	CcSEcCtD
Saquinavir—Erythema—Epirubicin—bone cancer	0.000104	0.000708	CcSEcCtD
Saquinavir—Eye disorder—Doxorubicin—bone cancer	0.000104	0.000703	CcSEcCtD
Saquinavir—Ill-defined disorder—Methotrexate—bone cancer	0.000103	0.000702	CcSEcCtD
Saquinavir—Tinnitus—Doxorubicin—bone cancer	0.000103	0.000702	CcSEcCtD
Saquinavir—Anaemia—Methotrexate—bone cancer	0.000103	0.000699	CcSEcCtD
Saquinavir—Cardiac disorder—Doxorubicin—bone cancer	0.000103	0.000698	CcSEcCtD
Saquinavir—Flatulence—Epirubicin—bone cancer	0.000103	0.000698	CcSEcCtD
Saquinavir—Dysgeusia—Epirubicin—bone cancer	0.000102	0.000693	CcSEcCtD
Saquinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000101	0.00204	CbGpPWpGaD
Saquinavir—Back pain—Epirubicin—bone cancer	0.000101	0.000685	CcSEcCtD
Saquinavir—Angiopathy—Doxorubicin—bone cancer	0.000101	0.000683	CcSEcCtD
Saquinavir—Malaise—Methotrexate—bone cancer	0.000101	0.000682	CcSEcCtD
Saquinavir—CYP11A1—Metabolism—NDUFA12—bone cancer	0.0001	0.00202	CbGpPWpGaD
Saquinavir—Muscle spasms—Epirubicin—bone cancer	0.0001	0.000681	CcSEcCtD
Saquinavir—Immune system disorder—Doxorubicin—bone cancer	0.0001	0.00068	CcSEcCtD
Saquinavir—Vertigo—Methotrexate—bone cancer	0.0001	0.00068	CcSEcCtD
Saquinavir—Mediastinal disorder—Doxorubicin—bone cancer	9.99e-05	0.000678	CcSEcCtD
Saquinavir—Leukopenia—Methotrexate—bone cancer	9.98e-05	0.000677	CcSEcCtD
Saquinavir—Chills—Doxorubicin—bone cancer	9.95e-05	0.000675	CcSEcCtD
Saquinavir—Nausea—Cisplatin—bone cancer	9.85e-05	0.000668	CcSEcCtD
Saquinavir—Alopecia—Doxorubicin—bone cancer	9.8e-05	0.000665	CcSEcCtD
Saquinavir—Cough—Methotrexate—bone cancer	9.73e-05	0.00066	CcSEcCtD
Saquinavir—Mental disorder—Doxorubicin—bone cancer	9.71e-05	0.000659	CcSEcCtD
Saquinavir—Ill-defined disorder—Epirubicin—bone cancer	9.68e-05	0.000657	CcSEcCtD
Saquinavir—Convulsion—Methotrexate—bone cancer	9.66e-05	0.000655	CcSEcCtD
Saquinavir—Malnutrition—Doxorubicin—bone cancer	9.65e-05	0.000655	CcSEcCtD
Saquinavir—Erythema—Doxorubicin—bone cancer	9.65e-05	0.000655	CcSEcCtD
Saquinavir—Anaemia—Epirubicin—bone cancer	9.64e-05	0.000654	CcSEcCtD
Saquinavir—CYP3A7—Biological oxidations—CYP3A4—bone cancer	9.63e-05	0.00194	CbGpPWpGaD
Saquinavir—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	9.6e-05	0.00193	CbGpPWpGaD
Saquinavir—Agitation—Epirubicin—bone cancer	9.59e-05	0.000651	CcSEcCtD
Saquinavir—Flatulence—Doxorubicin—bone cancer	9.51e-05	0.000646	CcSEcCtD
Saquinavir—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	9.5e-05	0.00191	CbGpPWpGaD
Saquinavir—Chest pain—Methotrexate—bone cancer	9.49e-05	0.000644	CcSEcCtD
Saquinavir—Arthralgia—Methotrexate—bone cancer	9.49e-05	0.000644	CcSEcCtD
Saquinavir—Myalgia—Methotrexate—bone cancer	9.49e-05	0.000644	CcSEcCtD
Saquinavir—Dysgeusia—Doxorubicin—bone cancer	9.45e-05	0.000642	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	9.43e-05	0.00064	CcSEcCtD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.41e-05	0.00189	CbGpPWpGaD
Saquinavir—Malaise—Epirubicin—bone cancer	9.41e-05	0.000638	CcSEcCtD
Saquinavir—Discomfort—Methotrexate—bone cancer	9.38e-05	0.000636	CcSEcCtD
Saquinavir—Vertigo—Epirubicin—bone cancer	9.37e-05	0.000636	CcSEcCtD
Saquinavir—Syncope—Epirubicin—bone cancer	9.36e-05	0.000635	CcSEcCtD
Saquinavir—Leukopenia—Epirubicin—bone cancer	9.34e-05	0.000634	CcSEcCtD
Saquinavir—Back pain—Doxorubicin—bone cancer	9.34e-05	0.000634	CcSEcCtD
Saquinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.32e-05	0.00188	CbGpPWpGaD
Saquinavir—Muscle spasms—Doxorubicin—bone cancer	9.28e-05	0.00063	CcSEcCtD
Saquinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.24e-05	0.00186	CbGpPWpGaD
Saquinavir—Confusional state—Methotrexate—bone cancer	9.17e-05	0.000623	CcSEcCtD
Saquinavir—Loss of consciousness—Epirubicin—bone cancer	9.17e-05	0.000622	CcSEcCtD
Saquinavir—Cough—Epirubicin—bone cancer	9.1e-05	0.000618	CcSEcCtD
Saquinavir—Convulsion—Epirubicin—bone cancer	9.04e-05	0.000613	CcSEcCtD
Saquinavir—Infection—Methotrexate—bone cancer	9.04e-05	0.000613	CcSEcCtD
Saquinavir—Hypertension—Epirubicin—bone cancer	9.01e-05	0.000611	CcSEcCtD
Saquinavir—Ill-defined disorder—Doxorubicin—bone cancer	8.96e-05	0.000608	CcSEcCtD
Saquinavir—Nervous system disorder—Methotrexate—bone cancer	8.92e-05	0.000606	CcSEcCtD
Saquinavir—Anaemia—Doxorubicin—bone cancer	8.92e-05	0.000605	CcSEcCtD
Saquinavir—Thrombocytopenia—Methotrexate—bone cancer	8.91e-05	0.000605	CcSEcCtD
Saquinavir—Myalgia—Epirubicin—bone cancer	8.88e-05	0.000603	CcSEcCtD
Saquinavir—Arthralgia—Epirubicin—bone cancer	8.88e-05	0.000603	CcSEcCtD
Saquinavir—Chest pain—Epirubicin—bone cancer	8.88e-05	0.000603	CcSEcCtD
Saquinavir—Agitation—Doxorubicin—bone cancer	8.87e-05	0.000602	CcSEcCtD
Saquinavir—Anxiety—Epirubicin—bone cancer	8.85e-05	0.000601	CcSEcCtD
Saquinavir—Skin disorder—Methotrexate—bone cancer	8.84e-05	0.0006	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	8.82e-05	0.000599	CcSEcCtD
Saquinavir—Hyperhidrosis—Methotrexate—bone cancer	8.8e-05	0.000597	CcSEcCtD
Saquinavir—Discomfort—Epirubicin—bone cancer	8.78e-05	0.000596	CcSEcCtD
Saquinavir—Malaise—Doxorubicin—bone cancer	8.7e-05	0.000591	CcSEcCtD
Saquinavir—Dry mouth—Epirubicin—bone cancer	8.69e-05	0.000589	CcSEcCtD
Saquinavir—Vertigo—Doxorubicin—bone cancer	8.67e-05	0.000589	CcSEcCtD
Saquinavir—Anorexia—Methotrexate—bone cancer	8.67e-05	0.000589	CcSEcCtD
Saquinavir—Syncope—Doxorubicin—bone cancer	8.66e-05	0.000587	CcSEcCtD
Saquinavir—Leukopenia—Doxorubicin—bone cancer	8.64e-05	0.000586	CcSEcCtD
Saquinavir—Confusional state—Epirubicin—bone cancer	8.58e-05	0.000583	CcSEcCtD
Saquinavir—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.57e-05	0.00172	CbGpPWpGaD
Saquinavir—Oedema—Epirubicin—bone cancer	8.51e-05	0.000578	CcSEcCtD
Saquinavir—Hypotension—Methotrexate—bone cancer	8.5e-05	0.000577	CcSEcCtD
Saquinavir—Loss of consciousness—Doxorubicin—bone cancer	8.48e-05	0.000576	CcSEcCtD
Saquinavir—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.47e-05	0.0017	CbGpPWpGaD
Saquinavir—Infection—Epirubicin—bone cancer	8.46e-05	0.000574	CcSEcCtD
Saquinavir—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	8.44e-05	0.0017	CbGpPWpGaD
Saquinavir—Cough—Doxorubicin—bone cancer	8.42e-05	0.000572	CcSEcCtD
Saquinavir—Shock—Epirubicin—bone cancer	8.38e-05	0.000568	CcSEcCtD
Saquinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.37e-05	0.00168	CbGpPWpGaD
Saquinavir—Convulsion—Doxorubicin—bone cancer	8.36e-05	0.000568	CcSEcCtD
Saquinavir—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	8.35e-05	0.00168	CbGpPWpGaD
Saquinavir—Nervous system disorder—Epirubicin—bone cancer	8.35e-05	0.000567	CcSEcCtD
Saquinavir—Thrombocytopenia—Epirubicin—bone cancer	8.34e-05	0.000566	CcSEcCtD
Saquinavir—Hypertension—Doxorubicin—bone cancer	8.33e-05	0.000566	CcSEcCtD
Saquinavir—CYP11A1—Metabolism—NT5C3A—bone cancer	8.32e-05	0.00167	CbGpPWpGaD
Saquinavir—Musculoskeletal discomfort—Methotrexate—bone cancer	8.29e-05	0.000563	CcSEcCtD
Saquinavir—Skin disorder—Epirubicin—bone cancer	8.27e-05	0.000561	CcSEcCtD
Saquinavir—CYP3A7—Biological oxidations—GSTP1—bone cancer	8.24e-05	0.00166	CbGpPWpGaD
Saquinavir—Hyperhidrosis—Epirubicin—bone cancer	8.23e-05	0.000559	CcSEcCtD
Saquinavir—Insomnia—Methotrexate—bone cancer	8.23e-05	0.000558	CcSEcCtD
Saquinavir—Chest pain—Doxorubicin—bone cancer	8.22e-05	0.000558	CcSEcCtD
Saquinavir—Arthralgia—Doxorubicin—bone cancer	8.22e-05	0.000558	CcSEcCtD
Saquinavir—Myalgia—Doxorubicin—bone cancer	8.22e-05	0.000558	CcSEcCtD
Saquinavir—Anxiety—Doxorubicin—bone cancer	8.19e-05	0.000556	CcSEcCtD
Saquinavir—Paraesthesia—Methotrexate—bone cancer	8.17e-05	0.000554	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	8.16e-05	0.000554	CcSEcCtD
Saquinavir—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	8.12e-05	0.00163	CbGpPWpGaD
Saquinavir—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.12e-05	0.00163	CbGpPWpGaD
Saquinavir—Discomfort—Doxorubicin—bone cancer	8.12e-05	0.000551	CcSEcCtD
Saquinavir—Anorexia—Epirubicin—bone cancer	8.12e-05	0.000551	CcSEcCtD
Saquinavir—Dyspnoea—Methotrexate—bone cancer	8.11e-05	0.00055	CcSEcCtD
Saquinavir—Somnolence—Methotrexate—bone cancer	8.09e-05	0.000549	CcSEcCtD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.05e-05	0.00162	CbGpPWpGaD
Saquinavir—Dry mouth—Doxorubicin—bone cancer	8.04e-05	0.000545	CcSEcCtD
Saquinavir—Dyspepsia—Methotrexate—bone cancer	8.01e-05	0.000544	CcSEcCtD
Saquinavir—Hypotension—Epirubicin—bone cancer	7.96e-05	0.00054	CcSEcCtD
Saquinavir—Confusional state—Doxorubicin—bone cancer	7.94e-05	0.000539	CcSEcCtD
Saquinavir—Decreased appetite—Methotrexate—bone cancer	7.91e-05	0.000537	CcSEcCtD
Saquinavir—Oedema—Doxorubicin—bone cancer	7.88e-05	0.000535	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Methotrexate—bone cancer	7.85e-05	0.000533	CcSEcCtD
Saquinavir—Fatigue—Methotrexate—bone cancer	7.84e-05	0.000532	CcSEcCtD
Saquinavir—Infection—Doxorubicin—bone cancer	7.83e-05	0.000531	CcSEcCtD
Saquinavir—Pain—Methotrexate—bone cancer	7.78e-05	0.000528	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Epirubicin—bone cancer	7.76e-05	0.000526	CcSEcCtD
Saquinavir—Shock—Doxorubicin—bone cancer	7.75e-05	0.000526	CcSEcCtD
Saquinavir—Nervous system disorder—Doxorubicin—bone cancer	7.73e-05	0.000524	CcSEcCtD
Saquinavir—Thrombocytopenia—Doxorubicin—bone cancer	7.71e-05	0.000523	CcSEcCtD
Saquinavir—Insomnia—Epirubicin—bone cancer	7.7e-05	0.000523	CcSEcCtD
Saquinavir—Skin disorder—Doxorubicin—bone cancer	7.65e-05	0.000519	CcSEcCtD
Saquinavir—Paraesthesia—Epirubicin—bone cancer	7.65e-05	0.000519	CcSEcCtD
Saquinavir—Hyperhidrosis—Doxorubicin—bone cancer	7.62e-05	0.000517	CcSEcCtD
Saquinavir—Dyspnoea—Epirubicin—bone cancer	7.59e-05	0.000515	CcSEcCtD
Saquinavir—Somnolence—Epirubicin—bone cancer	7.57e-05	0.000514	CcSEcCtD
Saquinavir—Anorexia—Doxorubicin—bone cancer	7.51e-05	0.00051	CcSEcCtD
Saquinavir—Feeling abnormal—Methotrexate—bone cancer	7.5e-05	0.000509	CcSEcCtD
Saquinavir—Dyspepsia—Epirubicin—bone cancer	7.49e-05	0.000509	CcSEcCtD
Saquinavir—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.45e-05	0.0015	CbGpPWpGaD
Saquinavir—Gastrointestinal pain—Methotrexate—bone cancer	7.44e-05	0.000505	CcSEcCtD
Saquinavir—Decreased appetite—Epirubicin—bone cancer	7.4e-05	0.000502	CcSEcCtD
Saquinavir—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.39e-05	0.00149	CbGpPWpGaD
Saquinavir—Hypotension—Doxorubicin—bone cancer	7.36e-05	0.0005	CcSEcCtD
Saquinavir—SLCO1A2—Metabolism—NDUFA12—bone cancer	7.36e-05	0.00148	CbGpPWpGaD
Saquinavir—Gastrointestinal disorder—Epirubicin—bone cancer	7.35e-05	0.000499	CcSEcCtD
Saquinavir—Fatigue—Epirubicin—bone cancer	7.34e-05	0.000498	CcSEcCtD
Saquinavir—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.31e-05	0.00147	CbGpPWpGaD
Saquinavir—Constipation—Epirubicin—bone cancer	7.28e-05	0.000494	CcSEcCtD
Saquinavir—Pain—Epirubicin—bone cancer	7.28e-05	0.000494	CcSEcCtD
Saquinavir—Urticaria—Methotrexate—bone cancer	7.23e-05	0.000491	CcSEcCtD
Saquinavir—Body temperature increased—Methotrexate—bone cancer	7.19e-05	0.000488	CcSEcCtD
Saquinavir—Abdominal pain—Methotrexate—bone cancer	7.19e-05	0.000488	CcSEcCtD
Saquinavir—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	7.18e-05	0.00144	CbGpPWpGaD
Saquinavir—Musculoskeletal discomfort—Doxorubicin—bone cancer	7.18e-05	0.000487	CcSEcCtD
Saquinavir—Insomnia—Doxorubicin—bone cancer	7.13e-05	0.000484	CcSEcCtD
Saquinavir—Paraesthesia—Doxorubicin—bone cancer	7.07e-05	0.00048	CcSEcCtD
Saquinavir—Dyspnoea—Doxorubicin—bone cancer	7.02e-05	0.000477	CcSEcCtD
Saquinavir—Feeling abnormal—Epirubicin—bone cancer	7.02e-05	0.000476	CcSEcCtD
Saquinavir—Somnolence—Doxorubicin—bone cancer	7e-05	0.000475	CcSEcCtD
Saquinavir—Gastrointestinal pain—Epirubicin—bone cancer	6.96e-05	0.000472	CcSEcCtD
Saquinavir—CYP3A5—Biological oxidations—CYP3A4—bone cancer	6.96e-05	0.0014	CbGpPWpGaD
Saquinavir—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.94e-05	0.0014	CbGpPWpGaD
Saquinavir—Dyspepsia—Doxorubicin—bone cancer	6.93e-05	0.000471	CcSEcCtD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.87e-05	0.00138	CbGpPWpGaD
Saquinavir—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	6.87e-05	0.00138	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	6.85e-05	0.00138	CbGpPWpGaD
Saquinavir—Decreased appetite—Doxorubicin—bone cancer	6.85e-05	0.000465	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Doxorubicin—bone cancer	6.8e-05	0.000462	CcSEcCtD
Saquinavir—Fatigue—Doxorubicin—bone cancer	6.79e-05	0.000461	CcSEcCtD
Saquinavir—Urticaria—Epirubicin—bone cancer	6.76e-05	0.000459	CcSEcCtD
Saquinavir—Constipation—Doxorubicin—bone cancer	6.74e-05	0.000457	CcSEcCtD
Saquinavir—Pain—Doxorubicin—bone cancer	6.74e-05	0.000457	CcSEcCtD
Saquinavir—Body temperature increased—Epirubicin—bone cancer	6.73e-05	0.000457	CcSEcCtD
Saquinavir—Abdominal pain—Epirubicin—bone cancer	6.73e-05	0.000457	CcSEcCtD
Saquinavir—Hypersensitivity—Methotrexate—bone cancer	6.7e-05	0.000455	CcSEcCtD
Saquinavir—ABCC1—Metabolism—NDUFA12—bone cancer	6.62e-05	0.00133	CbGpPWpGaD
Saquinavir—Asthenia—Methotrexate—bone cancer	6.53e-05	0.000443	CcSEcCtD
Saquinavir—Feeling abnormal—Doxorubicin—bone cancer	6.49e-05	0.000441	CcSEcCtD
Saquinavir—Gastrointestinal pain—Doxorubicin—bone cancer	6.44e-05	0.000437	CcSEcCtD
Saquinavir—Pruritus—Methotrexate—bone cancer	6.44e-05	0.000437	CcSEcCtD
Saquinavir—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.43e-05	0.00129	CbGpPWpGaD
Saquinavir—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	6.41e-05	0.00129	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—NDUFA12—bone cancer	6.29e-05	0.00127	CbGpPWpGaD
Saquinavir—Hypersensitivity—Epirubicin—bone cancer	6.27e-05	0.000426	CcSEcCtD
Saquinavir—Urticaria—Doxorubicin—bone cancer	6.26e-05	0.000425	CcSEcCtD
Saquinavir—Abdominal pain—Doxorubicin—bone cancer	6.23e-05	0.000423	CcSEcCtD
Saquinavir—Body temperature increased—Doxorubicin—bone cancer	6.23e-05	0.000423	CcSEcCtD
Saquinavir—Diarrhoea—Methotrexate—bone cancer	6.22e-05	0.000422	CcSEcCtD
Saquinavir—Asthenia—Epirubicin—bone cancer	6.11e-05	0.000415	CcSEcCtD
Saquinavir—SLCO1A2—Metabolism—NT5C3A—bone cancer	6.09e-05	0.00123	CbGpPWpGaD
Saquinavir—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.03e-05	0.00121	CbGpPWpGaD
Saquinavir—Pruritus—Epirubicin—bone cancer	6.02e-05	0.000409	CcSEcCtD
Saquinavir—Dizziness—Methotrexate—bone cancer	6.02e-05	0.000408	CcSEcCtD
Saquinavir—CYP3A5—Biological oxidations—GSTP1—bone cancer	5.95e-05	0.0012	CbGpPWpGaD
Saquinavir—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	5.95e-05	0.0012	CbGpPWpGaD
Saquinavir—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.93e-05	0.00119	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	5.92e-05	0.00119	CbGpPWpGaD
Saquinavir—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	5.87e-05	0.00118	CbGpPWpGaD
Saquinavir—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	5.84e-05	0.00118	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.83e-05	0.00117	CbGpPWpGaD
Saquinavir—Diarrhoea—Epirubicin—bone cancer	5.83e-05	0.000395	CcSEcCtD
Saquinavir—ABCG2—Metabolism—NDUFA12—bone cancer	5.82e-05	0.00117	CbGpPWpGaD
Saquinavir—Hypersensitivity—Doxorubicin—bone cancer	5.8e-05	0.000394	CcSEcCtD
Saquinavir—Vomiting—Methotrexate—bone cancer	5.78e-05	0.000393	CcSEcCtD
Saquinavir—CYP3A7—Metabolism—NDUFA12—bone cancer	5.77e-05	0.00116	CbGpPWpGaD
Saquinavir—Rash—Methotrexate—bone cancer	5.74e-05	0.000389	CcSEcCtD
Saquinavir—Dermatitis—Methotrexate—bone cancer	5.73e-05	0.000389	CcSEcCtD
Saquinavir—Headache—Methotrexate—bone cancer	5.7e-05	0.000387	CcSEcCtD
Saquinavir—Asthenia—Doxorubicin—bone cancer	5.65e-05	0.000384	CcSEcCtD
Saquinavir—Dizziness—Epirubicin—bone cancer	5.63e-05	0.000382	CcSEcCtD
Saquinavir—Pruritus—Doxorubicin—bone cancer	5.57e-05	0.000378	CcSEcCtD
Saquinavir—ABCC1—Metabolism—NT5C3A—bone cancer	5.48e-05	0.0011	CbGpPWpGaD
Saquinavir—Vomiting—Epirubicin—bone cancer	5.41e-05	0.000367	CcSEcCtD
Saquinavir—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	5.41e-05	0.00109	CbGpPWpGaD
Saquinavir—Nausea—Methotrexate—bone cancer	5.4e-05	0.000367	CcSEcCtD
Saquinavir—Diarrhoea—Doxorubicin—bone cancer	5.39e-05	0.000366	CcSEcCtD
Saquinavir—CYP2C19—Biological oxidations—CYP3A4—bone cancer	5.38e-05	0.00108	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—NDUFA12—bone cancer	5.37e-05	0.00108	CbGpPWpGaD
Saquinavir—Rash—Epirubicin—bone cancer	5.37e-05	0.000364	CcSEcCtD
Saquinavir—Dermatitis—Epirubicin—bone cancer	5.36e-05	0.000364	CcSEcCtD
Saquinavir—Headache—Epirubicin—bone cancer	5.33e-05	0.000362	CcSEcCtD
Saquinavir—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	5.31e-05	0.00107	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.3e-05	0.00107	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—NT5C3A—bone cancer	5.21e-05	0.00105	CbGpPWpGaD
Saquinavir—Dizziness—Doxorubicin—bone cancer	5.21e-05	0.000354	CcSEcCtD
Saquinavir—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.16e-05	0.00104	CbGpPWpGaD
Saquinavir—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.09e-05	0.00102	CbGpPWpGaD
Saquinavir—Nausea—Epirubicin—bone cancer	5.06e-05	0.000343	CcSEcCtD
Saquinavir—Vomiting—Doxorubicin—bone cancer	5.01e-05	0.00034	CcSEcCtD
Saquinavir—Rash—Doxorubicin—bone cancer	4.97e-05	0.000337	CcSEcCtD
Saquinavir—Dermatitis—Doxorubicin—bone cancer	4.96e-05	0.000337	CcSEcCtD
Saquinavir—CYP2D6—Biological oxidations—CYP3A4—bone cancer	4.95e-05	0.000996	CbGpPWpGaD
Saquinavir—Headache—Doxorubicin—bone cancer	4.94e-05	0.000335	CcSEcCtD
Saquinavir—CYP2C9—Biological oxidations—CYP3A4—bone cancer	4.91e-05	0.000988	CbGpPWpGaD
Saquinavir—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	4.91e-05	0.000987	CbGpPWpGaD
Saquinavir—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	4.88e-05	0.000983	CbGpPWpGaD
Saquinavir—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.84e-05	0.000974	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.83e-05	0.000972	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—NT5C3A—bone cancer	4.83e-05	0.000971	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—NT5C3A—bone cancer	4.78e-05	0.000963	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.77e-05	0.000959	CbGpPWpGaD
Saquinavir—Nausea—Doxorubicin—bone cancer	4.68e-05	0.000318	CcSEcCtD
Saquinavir—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.6e-05	0.000926	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.6e-05	0.000925	CbGpPWpGaD
Saquinavir—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	4.54e-05	0.000914	CbGpPWpGaD
Saquinavir—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.54e-05	0.000914	CbGpPWpGaD
Saquinavir—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.52e-05	0.000909	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—NT5C3A—bone cancer	4.45e-05	0.000896	CbGpPWpGaD
Saquinavir—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	4.36e-05	0.000877	CbGpPWpGaD
Saquinavir—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.27e-05	0.00086	CbGpPWpGaD
Saquinavir—CYP2D6—Biological oxidations—GSTP1—bone cancer	4.23e-05	0.000852	CbGpPWpGaD
Saquinavir—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.2e-05	0.000845	CbGpPWpGaD
Saquinavir—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	4.18e-05	0.00084	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—NDUFA12—bone cancer	4.17e-05	0.00084	CbGpPWpGaD
Saquinavir—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.14e-05	0.000833	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.04e-05	0.000813	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.03e-05	0.000811	CbGpPWpGaD
Saquinavir—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.97e-05	0.000799	CbGpPWpGaD
Saquinavir—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	3.65e-05	0.000735	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—ENO2—bone cancer	3.64e-05	0.000733	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—NDUFA12—bone cancer	3.61e-05	0.000727	CbGpPWpGaD
Saquinavir—ALB—Metabolism—NDUFA12—bone cancer	3.59e-05	0.000723	CbGpPWpGaD
Saquinavir—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.48e-05	0.0007	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—NT5C3A—bone cancer	3.46e-05	0.000696	CbGpPWpGaD
Saquinavir—ALB—Folate Metabolism—TP53—bone cancer	3.4e-05	0.000685	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—DHFR—bone cancer	3.38e-05	0.00068	CbGpPWpGaD
Saquinavir—SLC22A1—Neuronal System—BRAF—bone cancer	3.34e-05	0.000672	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—NDUFA12—bone cancer	3.23e-05	0.000649	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—GNA11—bone cancer	3.16e-05	0.000636	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NDUFA12—bone cancer	3.15e-05	0.000634	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—SPARC—bone cancer	3.05e-05	0.000614	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.99e-05	0.000603	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—NT5C3A—bone cancer	2.99e-05	0.000603	CbGpPWpGaD
Saquinavir—ALB—Metabolism—NT5C3A—bone cancer	2.98e-05	0.000599	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NDUFA12—bone cancer	2.97e-05	0.000597	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NDUFA12—bone cancer	2.94e-05	0.000592	CbGpPWpGaD
Saquinavir—ABCC1—Disease—ENO2—bone cancer	2.87e-05	0.000577	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—CYP3A4—bone cancer	2.86e-05	0.000576	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.85e-05	0.000573	CbGpPWpGaD
Saquinavir—SLC22A1—Neuronal System—MDM2—bone cancer	2.8e-05	0.000563	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—GNA11—bone cancer	2.79e-05	0.000561	CbGpPWpGaD
Saquinavir—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.77e-05	0.000557	CbGpPWpGaD
Saquinavir—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.73e-05	0.000549	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—NT5C3A—bone cancer	2.67e-05	0.000538	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—ENO2—bone cancer	2.67e-05	0.000537	CbGpPWpGaD
Saquinavir—ABCC1—Disease—DHFR—bone cancer	2.66e-05	0.000536	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—NT5C3A—bone cancer	2.61e-05	0.000525	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—IL3—bone cancer	2.53e-05	0.000509	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—DHFR—bone cancer	2.48e-05	0.000498	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—NT5C3A—bone cancer	2.46e-05	0.000495	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—GSTP1—bone cancer	2.45e-05	0.000493	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—NT5C3A—bone cancer	2.44e-05	0.000491	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—ENO2—bone cancer	2.4e-05	0.000483	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—GNA11—bone cancer	2.31e-05	0.000466	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—ENO2—bone cancer	2.28e-05	0.000459	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—DHFR—bone cancer	2.23e-05	0.000449	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.22e-05	0.000447	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.14e-05	0.000431	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—DHFR—bone cancer	2.12e-05	0.000426	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—ENO2—bone cancer	2.11e-05	0.000425	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.1e-05	0.000422	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—ENO2—bone cancer	2.1e-05	0.000422	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.09e-05	0.00042	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GNA11—bone cancer	2.08e-05	0.000419	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GNA11—bone cancer	1.98e-05	0.000398	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—DHFR—bone cancer	1.96e-05	0.000395	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—ENO2—bone cancer	1.95e-05	0.000392	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—DHFR—bone cancer	1.94e-05	0.000391	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NDUFA12—bone cancer	1.94e-05	0.00039	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.93e-05	0.000388	CbGpPWpGaD
Saquinavir—ABCC1—Disease—TGFBR2—bone cancer	1.93e-05	0.000388	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—CYP3A4—bone cancer	1.89e-05	0.00038	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.88e-05	0.000378	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GNA11—bone cancer	1.83e-05	0.000369	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GNA11—bone cancer	1.82e-05	0.000366	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—DHFR—bone cancer	1.81e-05	0.000364	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—GSTP1—bone cancer	1.79e-05	0.000361	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.79e-05	0.000361	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.79e-05	0.000359	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GNA11—bone cancer	1.69e-05	0.00034	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—CYP3A4—bone cancer	1.66e-05	0.000334	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—PLAU—bone cancer	1.66e-05	0.000334	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—CYP3A4—bone cancer	1.65e-05	0.000331	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—GSTP1—bone cancer	1.62e-05	0.000325	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—NT5C3A—bone cancer	1.61e-05	0.000324	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—GSTP1—bone cancer	1.53e-05	0.000309	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—CYP3A4—bone cancer	1.53e-05	0.000308	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.52e-05	0.000305	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—ENO2—bone cancer	1.51e-05	0.000305	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—GSTP1—bone cancer	1.42e-05	0.000286	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—GSTP1—bone cancer	1.41e-05	0.000284	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—DHFR—bone cancer	1.41e-05	0.000283	CbGpPWpGaD
Saquinavir—ABCC1—Disease—KIT—bone cancer	1.32e-05	0.000265	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GNA11—bone cancer	1.31e-05	0.000264	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—ENO2—bone cancer	1.31e-05	0.000264	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—GSTP1—bone cancer	1.31e-05	0.000264	CbGpPWpGaD
Saquinavir—ALB—Metabolism—ENO2—bone cancer	1.3e-05	0.000263	CbGpPWpGaD
Saquinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.27e-05	0.000256	CbGpPWpGaD
Saquinavir—CYP11A1—Metabolism—PTGS2—bone cancer	1.27e-05	0.000255	CbGpPWpGaD
Saquinavir—ABCC1—Disease—BRAF—bone cancer	1.24e-05	0.000249	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—DHFR—bone cancer	1.22e-05	0.000245	CbGpPWpGaD
Saquinavir—ALB—Metabolism—DHFR—bone cancer	1.21e-05	0.000244	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—CYP3A4—bone cancer	1.19e-05	0.00024	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—ENO2—bone cancer	1.17e-05	0.000236	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—ENO2—bone cancer	1.14e-05	0.00023	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GNA11—bone cancer	1.14e-05	0.000229	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GNA11—bone cancer	1.13e-05	0.000228	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—DHFR—bone cancer	1.09e-05	0.000219	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—ENO2—bone cancer	1.08e-05	0.000217	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—ENO2—bone cancer	1.07e-05	0.000215	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—DHFR—bone cancer	1.06e-05	0.000213	CbGpPWpGaD
Saquinavir—ABCC1—Disease—MDM2—bone cancer	1.04e-05	0.000209	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—CYP3A4—bone cancer	1.03e-05	0.000208	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.03e-05	0.000206	CbGpPWpGaD
Saquinavir—ALB—Metabolism—CYP3A4—bone cancer	1.03e-05	0.000206	CbGpPWpGaD
Saquinavir—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.02e-05	0.000205	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—GSTP1—bone cancer	1.02e-05	0.000205	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GNA11—bone cancer	1.02e-05	0.000204	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—DHFR—bone cancer	9.99e-06	0.000201	CbGpPWpGaD
Saquinavir—ABCC1—Disease—PTGS2—bone cancer	9.99e-06	0.000201	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GNA11—bone cancer	9.91e-06	0.000199	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—DHFR—bone cancer	9.9e-06	0.000199	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GNA11—bone cancer	9.34e-06	0.000188	CbGpPWpGaD
Saquinavir—SLCO1A2—Metabolism—PTGS2—bone cancer	9.3e-06	0.000187	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GNA11—bone cancer	9.26e-06	0.000186	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—CYP3A4—bone cancer	9.2e-06	0.000185	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.16e-06	0.000184	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—CYP3A4—bone cancer	8.98e-06	0.000181	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—GSTP1—bone cancer	8.82e-06	0.000178	CbGpPWpGaD
Saquinavir—ALB—Metabolism—GSTP1—bone cancer	8.77e-06	0.000176	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—CYP3A4—bone cancer	8.47e-06	0.00017	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—CYP3A4—bone cancer	8.39e-06	0.000169	CbGpPWpGaD
Saquinavir—ABCC1—Metabolism—PTGS2—bone cancer	8.37e-06	0.000168	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.35e-06	0.000168	CbGpPWpGaD
Saquinavir—SLCO1B1—Metabolism—PTGS2—bone cancer	7.95e-06	0.00016	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—GSTP1—bone cancer	7.87e-06	0.000158	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—GSTP1—bone cancer	7.68e-06	0.000155	CbGpPWpGaD
Saquinavir—ABCG2—Metabolism—PTGS2—bone cancer	7.36e-06	0.000148	CbGpPWpGaD
Saquinavir—CYP3A7—Metabolism—PTGS2—bone cancer	7.3e-06	0.000147	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—GSTP1—bone cancer	7.24e-06	0.000146	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—GSTP1—bone cancer	7.18e-06	0.000144	CbGpPWpGaD
Saquinavir—ABCC1—Disease—EGFR—bone cancer	7.08e-06	0.000143	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—ENO2—bone cancer	7.04e-06	0.000142	CbGpPWpGaD
Saquinavir—SLC22A1—Metabolism—PTGS2—bone cancer	6.79e-06	0.000137	CbGpPWpGaD
Saquinavir—ALB—Hemostasis—TP53—bone cancer	6.67e-06	0.000134	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—DHFR—bone cancer	6.53e-06	0.000131	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GNA11—bone cancer	6.11e-06	0.000123	CbGpPWpGaD
Saquinavir—CYP3A5—Metabolism—PTGS2—bone cancer	5.28e-06	0.000106	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—GSTP1—bone cancer	4.73e-06	9.53e-05	CbGpPWpGaD
Saquinavir—CYP2C8—Metabolism—PTGS2—bone cancer	4.57e-06	9.2e-05	CbGpPWpGaD
Saquinavir—ALB—Metabolism—PTGS2—bone cancer	4.54e-06	9.14e-05	CbGpPWpGaD
Saquinavir—CYP2C19—Metabolism—PTGS2—bone cancer	4.08e-06	8.21e-05	CbGpPWpGaD
Saquinavir—ABCB1—Metabolism—PTGS2—bone cancer	3.98e-06	8.01e-05	CbGpPWpGaD
Saquinavir—CYP2D6—Metabolism—PTGS2—bone cancer	3.75e-06	7.55e-05	CbGpPWpGaD
Saquinavir—CYP2C9—Metabolism—PTGS2—bone cancer	3.72e-06	7.48e-05	CbGpPWpGaD
Saquinavir—CYP3A4—Metabolism—PTGS2—bone cancer	2.45e-06	4.94e-05	CbGpPWpGaD
